top of page
Newsroom
Check on PrIMAVeRa's latest news


PrIMAVeRa participates in AMR Accelerator Cross-Project Meeting 2024
The Cross-Project Meeting gathered nearly 40 participants representing 9 IHI-funded projects from the AMR Accelerator, in Basel, Switzerland
Mar 8, 2024


PrIMAVeRa provides in-depth reports on current evidence base of burden of AMR in Europe
The PrIMAVeRa project proudly announces the simultaneous publication of four informative systematic reviews.
Nov 24, 2023


PrIMAVeRa 2nd annual meeting successfully held in hybrid format in Utrecht on 15-16 November 2023
The meeting enabled dynamic panel discussions covering the burden of AMR, and model development and data access.
Nov 24, 2023


PrIMAVeRa Project Appoints Scientific Advisory Committee
The PrIMAVeRa project announces the appointment of the Scientific Advisory Committee (SAC).
Jun 19, 2023


PrIMAVeRa 1st annual meeting successfully held in a hybrid event in Verona on 29-30 November 2022
PrIMAVeRa team gathered for the first project annual meeting with around 30 project partners joining in Verona (IT), and virtually.
Nov 30, 2022


PrIMAVeRa WP2 workshop, virtually held on 27-28 January 2022
The 2-day workshop included an overview of WP2, presentation and discussion of AMR case studies, the draft of AMR protocol, and more.
Feb 3, 2022


PrIMAVeRa kick-off meeting successfully marks the official project launch
The PrIMAVeRa consortium held its Kick-off Meeting on 25 November 2021 marking the official launch of this ambitious endeavor.
Dec 15, 2021


PrIMAVeRa, an ambitious project to demonstrate how vaccines can combat AMR
The IMI2 Joint Undertaking mobilises more than € 9 million to harnessing the power of big data and AI to steer the fight against AMR
Nov 9, 2021
bottom of page
